期刊文献+

高血压性心肌纤维化的药物治疗进展 被引量:3

Current Research on Treatment of Myocardial Fibrosis in Hypertension
下载PDF
导出
摘要 长期压力负荷增高引起的心肌纤维化可增加心血管不良事件的发生,严重影响高血压的预后和治疗。研究显示药物可逆转心肌纤维化以改善心脏功能。近年来发现除部分降压药外,还有很多其他药物如糜蛋白抑制剂、选择性醛固酮拮抗剂、过氧化物酶体增生物激活受体激动剂等也可逆转心肌纤维化。现就高血压性心肌纤维化的药物治疗研究报道进行综述。 Long-standing arterial hypertension can cause myocardial fibrosis, which contributes to abnormalities of cardiovascular function and seriously affects the prognosis and cure of hypertension. Research has proven that drugs can reverse myocardial fibrosis and improve heart function. Except for some anti-hypertensive drugs, many other drugs are found to can attenuate myocardial fibrosis, such as chymotrypsin inhibitor, selective aldosterone antagonists, PPAR excitomotor, et al. This paper reviews the current studies about reversing myocardial fibrosis from hypertension using drug therapy.
出处 《心血管病学进展》 CAS 2009年第1期75-78,共4页 Advances in Cardiovascular Diseases
基金 教育部高等学校博士学科点专项科研基金课题资助(20070533033)
关键词 高血压 心肌纤维化 药物 hypertension myocardial fibrosis drug therapy
  • 相关文献

参考文献30

  • 1Diez J, Lopez B, Gonzales A, et al. Clinical aspects of hypertensive myocardial fibrosis[ J]. Curt Opin Cardiol,2001,16(6) :328-335.
  • 2Gradman AH, Alfayoumi F. From left ventricular hypertrophy to congestive heart failure:management of hypertensive heart disease [ J]. Prog Cardiovasc Dis, 2006,48 ( 5 ) : 326-341.
  • 3朱伟旺,赵凤琴.替米沙坦对自发性高血压大鼠左心室重塑的影响[J].中国心血管病研究,2007,5(8):600-602. 被引量:4
  • 4Schannwell CM, Hennersdorf MG, Strauer BE. Hypertensive myocardial fibrosis [ J ]. Internist ( Berl ), 2007,48 ( 9 ) :909-920.
  • 5Kawai M, Morimoto S, Komukai K, et al. The novel angiotensin receptor blocker, telmisartan prevents myocardial hypertrophy and fibrosis in renovascular hypertensive (Go dblatt) rat[ J]. J Mol Cel Cardiol,2008,44(2) :435--448.
  • 6Anan F,Takahashi N ,Ooie T,et al. Effects of valsartan and perindopril combination therapy on left ventricular hypertrophy and aortic arterial stiffness in patients with essential hypertension[ J]. Eur J Clin Pharmaeol,2005,61 (5-6) :353-359.
  • 7Rietzachel ER, Boeykens E, de Buyzere ML, et al. A comparison between systolic and diastolic pulse contour analysis in the evaluation of arterial stiffness[ J]. Hypertension, 2001,37 ( 6 ) : E 15-22.
  • 8赵红,李海涛,顾定伟,李丽华.口服小剂量螺内酯抗高血压大鼠心肌纤维化[J].中华老年心脑血管病杂志,2007,9(10):693-695. 被引量:4
  • 9Okada T,Nagai M ,Taniguchi I ,et al. Combined treatment with valsartan and spironolactone prevents cardiovascular remodeling in renovascular hypertensive rats [J]. Int Heart J ,2006,47(5) :783-793.
  • 10Marano G, Palazzesi S, Vergari A, et al. Inhibition of left ventrieular remodelling preserves chamber systolic function in pressure-overloaded mice [ J ]. Pflugers Arch,2003,446 (4) :429-436.

二级参考文献7

共引文献6

同被引文献31

引证文献3

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部